172 related articles for article (PubMed ID: 23874490)
1. Passive immunization with hypochlorite-oxLDL specific antibodies reduces plaque volume in LDL receptor-deficient mice.
van Leeuwen M; Kemna MJ; de Winther MP; Boon L; Duijvestijn AM; Henatsch D; Bos NA; Gijbels MJ; Tervaert JW
PLoS One; 2013; 8(7):e68039. PubMed ID: 23874490
[TBL] [Abstract][Full Text] [Related]
2. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
Faria-Neto JR; Chyu KY; Li X; Dimayuga PC; Ferreira C; Yano J; Cercek B; Shah PK
Atherosclerosis; 2006 Nov; 189(1):83-90. PubMed ID: 16386745
[TBL] [Abstract][Full Text] [Related]
3. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring.
Yamashita T; Freigang S; Eberle C; Pattison J; Gupta S; Napoli C; Palinski W
Circ Res; 2006 Sep; 99(7):e51-64. PubMed ID: 16946133
[TBL] [Abstract][Full Text] [Related]
4. Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein.
Kyrklund M; Kummu O; Kankaanpää J; Akhi R; Nissinen A; Turunen SP; Pussinen P; Wang C; Hörkkö S
PLoS One; 2018; 13(1):e0191216. PubMed ID: 29329335
[TBL] [Abstract][Full Text] [Related]
5. Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice.
Smook ML; van Leeuwen M; Heeringa P; Damoiseaux JG; Theunissen R; Daemen MJ; Lutgens E; Tervaert JW
Clin Exp Immunol; 2008 Nov; 154(2):264-9. PubMed ID: 18778362
[TBL] [Abstract][Full Text] [Related]
6. Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE-/- mice.
Cesena FH; Dimayuga PC; Yano J; Zhao X; Kirzner J; Zhou J; Chan LF; Lio WM; Cercek B; Shah PK; Chyu KY
Atherosclerosis; 2012 Jan; 220(1):59-65. PubMed ID: 22062590
[TBL] [Abstract][Full Text] [Related]
7. Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr
Jeurissen MLJ; Walenbergh SMA; Houben T; Gijbels MJJ; Li J; Hendrikx T; Oligschlaeger Y; van Gorp PJ; Binder CJ; Donners MMPC; Shiri-Sverdlov R
Atherosclerosis; 2016 Dec; 255():59-65. PubMed ID: 27816810
[TBL] [Abstract][Full Text] [Related]
8. Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.
Habets KL; van Puijvelde GH; van Duivenvoorde LM; van Wanrooij EJ; de Vos P; Tervaert JW; van Berkel TJ; Toes RE; Kuiper J
Cardiovasc Res; 2010 Feb; 85(3):622-30. PubMed ID: 19819882
[TBL] [Abstract][Full Text] [Related]
9. The IgM response to modified LDL in experimental atherosclerosis: hypochlorite-modified LDL IgM antibodies versus classical natural T15 IgM antibodies.
van Leeuwen M; Damoiseaux J; Duijvestijn A; Heeringa P; Gijbels M; de Winther M; Tervaert JW
Ann N Y Acad Sci; 2009 Sep; 1173():274-9. PubMed ID: 19758162
[TBL] [Abstract][Full Text] [Related]
10. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.
Tsimikas S; Palinski W; Witztum JL
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):95-100. PubMed ID: 11145939
[TBL] [Abstract][Full Text] [Related]
11. The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice.
Pedersen TX; Binder CJ; Fredrikson GN; Nilsson J; Bro S; Nielsen LB
Nephrol Dial Transplant; 2010 Aug; 25(8):2486-91. PubMed ID: 20164045
[TBL] [Abstract][Full Text] [Related]
12. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against electronegative LDL inhibit atherosclerosis in LDLr-/- mice.
Grosso DM; Ferderbar S; Wanschel AC; Krieger MH; Higushi ML; Abdalla DS
Braz J Med Biol Res; 2008 Dec; 41(12):1086-92. PubMed ID: 19148370
[TBL] [Abstract][Full Text] [Related]
14. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
Freigang S; Hörkkö S; Miller E; Witztum JL; Palinski W
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1972-82. PubMed ID: 9848892
[TBL] [Abstract][Full Text] [Related]
15. Auto-Antibody Production During Experimental Atherosclerosis in
Hutchinson MA; Park HS; Zanotti KJ; Alvarez-Gonzalez J; Zhang J; Zhang L; Telljohann R; Wang M; Lakatta EG; Gearhart PJ; Maul RW
Front Immunol; 2021; 12():695220. PubMed ID: 34305930
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.
Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO
Circulation; 2009 Aug; 120(5):417-26. PubMed ID: 19620499
[TBL] [Abstract][Full Text] [Related]
17. B cell depletion reduces the development of atherosclerosis in mice.
Ait-Oufella H; Herbin O; Bouaziz JD; Binder CJ; Uyttenhove C; Laurans L; Taleb S; Van Vré E; Esposito B; Vilar J; Sirvent J; Van Snick J; Tedgui A; Tedder TF; Mallat Z
J Exp Med; 2010 Aug; 207(8):1579-87. PubMed ID: 20603314
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.
Binder CJ; Hörkkö S; Dewan A; Chang MK; Kieu EP; Goodyear CS; Shaw PX; Palinski W; Witztum JL; Silverman GJ
Nat Med; 2003 Jun; 9(6):736-43. PubMed ID: 12740573
[TBL] [Abstract][Full Text] [Related]
19. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
[TBL] [Abstract][Full Text] [Related]
20. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression.
Tsimikas S; Shortal BP; Witztum JL; Palinski W
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):689-97. PubMed ID: 10712392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
